LifeMD (LFMD) Aktie Kurs
LifeMD Kurs
Omsætningen er vokset med 39,6 % om året de seneste 15 år til 194,06 Mio. USD. LifeMDs nettoavance ligger på -3,7 %, op fra -65,6 % for flere år siden. Analytikernes mediankursmål er 8,00 USD, hvilket er over den aktuelle kurs med 237,6 %. Af 14 analytikere anbefaler 13 køb — den samlede vurdering er Køb.
LifeMD aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
LifeMD aktie og aktieanalyse
Hyppigt stillede spørgsmål om LifeMD-aktien
LifeMD Inc is a leading telehealth company that focuses on providing customized and convenient healthcare solutions to its customers. The business model of LifeMD Inc revolves around offering telemedicine consultations, prescription medications, and direct-to-consumer laboratory testing services. By leveraging advanced technology and a team of experienced healthcare professionals, LifeMD Inc aims to improve access to high-quality healthcare for individuals seeking personalized treatment options.
LifeMD Inc is primarily active in the telemedicine and healthcare industries.
The main competitors of LifeMD Inc in the market include companies like Teladoc Health, Amwell, and Hims & Hers. These companies also provide telemedicine and telehealth services, offering similar solutions to LifeMD Inc. However, LifeMD Inc distinguishes itself by focusing on a comprehensive approach to men's and women's healthcare needs, with a range of services including telemedicine consultations, hormone therapy, and at-home testing kits. LifeMD Inc aims to provide personalized healthcare solutions that cater specifically to individuals' wellness goals.
LifeMD Inc. is a healthcare technology company founded in 2020. It specializes in telemedicine and virtual care solutions, offering a wide range of personalized healthcare services. LifeMD Inc. has garnered recognition for its innovative platform that connects patients with licensed healthcare providers remotely. The company's mission is to improve access to quality healthcare by leveraging technology. LifeMD Inc. aims to deliver personalized, convenient, and affordable healthcare services to individuals across various medical specialties. With its cutting-edge telemedicine platform, the company is revolutionizing the way people receive medical care, enabling them to access top-notch healthcare services from the comfort of their homes.
LifeMD Inc has achieved several significant milestones since its inception. The company has gained recognition for its innovative telemedicine platform, providing accessible and affordable healthcare solutions to patients. In addition, LifeMD has successfully expanded its product offerings, introducing a comprehensive range of medical treatments and therapies tailored to various health concerns. The company has also demonstrated strong financial growth, realizing increased revenues and expanding its customer base. With its commitment to revolutionizing the healthcare industry, LifeMD Inc continues to deliver cutting-edge solutions and improve the overall well-being of individuals around the world.
LifeMD Inc is primarily present in the United States.
LifeMD Inc represents a set of core values and a strong corporate philosophy. With a focus on improving the health and well-being of individuals, LifeMD is committed to offering innovative telemedicine and virtual care solutions. The company prioritizes patient-centered care, convenience, and accessibility, aiming to revolutionize the way healthcare is delivered. LifeMD's corporate philosophy revolves around providing personalized and comprehensive medical services through its team of experienced healthcare professionals. By leveraging advanced technology and a patient-centric approach, LifeMD Inc is dedicated to enhancing the quality of healthcare for its customers and making a positive impact on their overall wellness.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 7,67 USD for LifeMD-aktien (median: 8,00 USD), svarende til +223,6 % i forhold til seneste kurs. Konsensus bygger på 14 analytikervurderinger.
14 analytikere vurderer i øjeblikket LifeMD-aktien: 13 anbefaler køb, 1 hold og 0 salg. For 2026 forventer analytikere, at LifeMD genererer omsætning på 207,61 Mio. USD og indtjening pr. aktie på -0,53 USD.
Omregnet til den aktuelle valutakurs handles LifeMD-aktien til 2,12 EUR (2,37 USD).
LifeMD-aktien (LFMD) er noteret på 1 børser, herunder: NASDAQ (LFMD).
The company LifeMD Inc is a US-American company specialized in providing telemedicine services. They offer various medical fields such as general medicine, gynecology, dermatology, urology, and psychiatry. The company's goal is to provide a fast, convenient, and cost-effective way to access medical advice and treatment. They have built a network of licensed doctors who are available for video chat or phone calls. Customers can book appointments through the LifeMD app or website and speak with a doctor within minutes. They also offer in-person visits at LifeMD clinics or in-home visits. In addition to telemedicine services, LifeMD also provides nutrition counseling, fitness and health programs, and a wide range of supplements made from natural ingredients. They focus on providing anti-aging products and services such as hormone replacement therapies, hair plasma therapies, and skincare products. LifeMD operates on a monthly subscription model, where customers can access all available services for a monthly fee. Prices for subscriptions range from $49.99 for a basic membership to $249.99 for a premium membership. LifeMD stands out from other providers by offering comprehensive digital healthcare services, allowing customers to access medical care from anywhere. It is a convenient alternative for people who live far from doctors or have limited time for appointments. Especially during the COVID-19 pandemic, LifeMD provides a safe environment for medical advice and care. In summary, LifeMD offers an innovative and holistic concept for healthcare. With a wide range of medical, nutrition, and anti-aging services, the company can meet individual needs and ensure optimal care. Thanks to the monthly subscription model, LifeMD is accessible to a broad target audience and offers a flexible and cost-effective alternative to traditional healthcare.
forventet-omsætningen for LifeMD er 207,61 Mio. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
forventet-overskuddet for LifeMD er -24,96 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for LifeMD er i øjeblikket -4,44. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af LifeMD-aktien.
Pris-til-salgs-forholdet (P/S) for LifeMD er i øjeblikket 0,53. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for LifeMD-aktien.
AlleAktien-kvalitetsscore for LifeMD er 4/10.
ISIN for LifeMD er US53216B1044. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
Tickeren for LifeMD er LFMD. Tickersymbolet bruges til at handle LifeMD-aktier på børsen.
LifeMD aktie
LifeMD Peer Group
LifeMD Ticker
LifeMD FIGI
Alle fundamentale data om LifeMD i deep dive
Vores aktieanalyse af LifeMD-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos LifeMD. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: